Close
Biotechgate
| |

Home Page

Action required: Please refresh your browser

We have recently implemented some changes that require a hard refresh of your browser: Please hold down the CTRL-key and press the F5 key.
After a successful hard refresh, this message should not appear anymore.

More details about this topic are available here »

News in the Life Sciences Industry
Results 41 - 60 out of 500 displayed.
«  1  2 3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25 »
Reset  ↻

BioCryst Announces Approval of ORLADEYO® (berotralstat) by the National Administration of Drugs, Foods, and Medical Devices (ANMAT) in Argentina

Read more ››
By: GlobeNewswire - 29 Nov 2023
Related companies:  BioCryst Pharmaceuticals, Inc.

Athira Pharma to Participate in Sidoti December Small Cap Investor Conference

Read more ››
By: GlobeNewswire - 29 Nov 2023
Related companies:  Athira Pharma, Inc.

KSQ Therapeutics Announces FDA Clearance of IND Application for KSQ-001EX, a CRISPR/Cas9 Engineered Tumor Infiltrating Lymphocyte (eTIL®) Therapy

Read more ››
By: GlobeNewswire - 29 Nov 2023
Related companies:  KSQ Therapeutics, Inc.

LSL Pharma Group Announces its Results for the Third Quarter of Fiscal 2023

Read more ››
By: GlobeNewswire - 29 Nov 2023

uniQure Announces FDA Clearance of Investigational New Drug Application for AMT-191 Gene Therapy for Fabry Disease

Read more ››
By: GlobeNewswire - 29 Nov 2023
Related companies:  uniQure N.V.

22nd Century Appoints Larry Firestone as Chairman and CEO

Read more ››
By: GlobeNewswire - 29 Nov 2023
Related companies:  22nd Century Group, Inc.

Eagle Pharmaceuticals Announces Management Change

Read more ››
By: GlobeNewswire - 29 Nov 2023
Related companies:  Eagle Pharmaceuticals Inc.

Apollomics to Participate in a Fireside Chat at the H.C. Wainwright 4th Annual Precision Oncology Virtual Conference

Read more ››
By: GlobeNewswire - 29 Nov 2023
Related companies:  Apollomics, Inc.

Ocugen CEO to Present at NobleCon19 – Noble Capital Markets’ Nineteenth Annual Emerging Growth Equity Conference

Read more ››
By: GlobeNewswire - 29 Nov 2023
Related companies:  Ocugen, Inc.

Jushi Holdings Inc. Announces Filing of Preliminary Base Shelf Prospectus

Read more ››
By: GlobeNewswire - 29 Nov 2023

Eagle Pharmaceuticals Announces Receipt of Notification of Deficiency from Nasdaq Regarding Requirement to Timely File Quarterly Report on Form 10-Q

Read more ››
By: GlobeNewswire - 29 Nov 2023
Related companies:  Eagle Pharmaceuticals Inc.

Plus Therapeutics to Present at the 5th Targeted Radiopharmaceuticals Summit Europe

Read more ››
By: GlobeNewswire - 29 Nov 2023
Related companies:  Plus Therapeutics, Inc.

Cogent Biosciences Announces Poster Presentations at Upcoming San Antonio Breast Cancer Symposium

Read more ››
By: GlobeNewswire - 29 Nov 2023
Related companies:  Cogent Biosciences, Inc.

BrightInsight Ranked 307th Fastest-Growing Company in North America on the 2023 Deloitte Technology Fast 500

Read more ››
By: GlobeNewswire - 29 Nov 2023
Related companies:  BrightInsight, Inc.

INmune Bio Inc. Demonstrates that INB03 Enhances the Uptake of Trastuzumab Deruxtecan in HER2+ Breast Cancer with MUC4 Expression in Poster Presented at San Antonio Breast Cancer Symposium

Read more ››
By: GlobeNewswire - 29 Nov 2023
Related companies:  INmune Bio Inc.

FDA Accepts Arcutis’ Supplemental New Drug Application for Roflumilast Cream 0.15% for the Treatment of Atopic Dermatitis in Adults and Children Down to Age 6

Read more ››
By: GlobeNewswire - 29 Nov 2023
Related companies:  Arcutis Biotherapeutics, Inc.

Vittoria Biotherapeutics Announces the Presentation of New Data Supporting the Company's Platform at the 65th American Society of Hematology Annual Meeting

Read more ››
By: GlobeNewswire - 29 Nov 2023
Related companies:  Vittoria Biotherapeutics, Inc.

Cocrystal Pharma Highlights its Novel Inhaled and Oral Influenza A Antiviral CC-42344 at the World Vaccine Congress West Coast

Read more ››
By: GlobeNewswire - 29 Nov 2023
Related companies:  Cocrystal Pharma, Inc.

Taysha Gene Therapies Announces Expanded Eligibility in REVEAL Phase 1/2 Adult Trial to Include Adolescent Rett Syndrome Patients

Read more ››
By: GlobeNewswire - 29 Nov 2023
Related companies:  Taysha Gene Therapies, Inc.

BioVie Announces Efficacy Data from Phase 3 Trial of NE3107 in Patients with Mild to Moderate Alzheimer’s Disease

Read more ››
By: GlobeNewswire - 29 Nov 2023
Related companies:  BioVie Inc.
«  1  2 3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25 »
Terms of Use & Privacy Policy
to the top ↑